Corrigendum: The role of 18F−FDG PET in predicting the pathological response and prognosis to unresectable HCC patients treated with lenvatinib and PD-1 inhibitors as a conversion therapy - Wang, Guanyun; Zhang, Wenwen; Luan, Xiaohui; Wang, Zhanbo; Liu, Jiajin; Xu, Xiaodan; Zhang, Jinming; Xu, Baixuan; Lu, Shichun; Wang, Ruimin; Ma, Guangyu (Frontiers in Immunology, 2023)